Negative predictive value of pleural fluid cytology in patients with a background of cancer.

O. Castro Anon (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), D. Mccracken (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), A. Dudina (Oxford, United Kingdom), Q. Lu (Oxford, United Kingdom), M. Tsikrika (Oxford, United Kingdom), R. Varatharajah (Oxford, United Kingdom), G. Shepherd (Oxford, United Kingdom), A. Thayanandan (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), J. Wrightson (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)

Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Session: Novel approaches to pleural effusion: should I change my practice?
Session type: Oral Presentation
Number: 494
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Castro Anon (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), D. Mccracken (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), A. Dudina (Oxford, United Kingdom), Q. Lu (Oxford, United Kingdom), M. Tsikrika (Oxford, United Kingdom), R. Varatharajah (Oxford, United Kingdom), G. Shepherd (Oxford, United Kingdom), A. Thayanandan (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), J. Wrightson (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom). Negative predictive value of pleural fluid cytology in patients with a background of cancer.. 494

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The value of sputum cytology in the diagnosis of lung malignancy
Source: Eur Respir J 2007; 30: Suppl. 51, 429s
Year: 2007

Negative predictive value of EBUS-TBNA in mediastinal staging of lung cancer
Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Year: 2020


Negative predictive value of EBUS in lung cancer staging
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012


Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020



Prognosis of patients with NSCLC undergoing positive pleural lavage cytology
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008


Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012

Could microsatellite analysis of pleural fluid increase sensitivity of pleural fluid cytology?
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007


Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 528s
Year: 2004

Negative predictive value of autofluorescence imaging (AFI) in patients at high risk for lung cancer
Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Year: 2007


The diagnostic value of CA-125 in pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 386s
Year: 2001

The value of cytology in pleural effusions vs histology by medical thoracoscopy
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung?
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019




Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Assessment of the negative predictive value (NPV) of endobronchial ultrasound-guided real-time needle aspiration (EBUS-rtNA) in mediastinal lymph node staging in patients with lung cancer based on surgical results
Source: Annual Congress 2008 - Ways into the mediastinum
Year: 2008

Diagnostic value of pleural effusion for the detection of EGFR in NSCLC: a meta-analysis
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019


Shox2, a biomarker for confirming malignancy in bronchial lavage from patients with suspected lung cancer and inconclusive cytology
Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Year: 2009


Rinse fluid cytology specimens add value to standard bronchoscopic sampling techniques in the diagnosis of lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 361s
Year: 2003

Diagnostic value of a third pleural biopsy
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Diagnostic utility of pleural CEA and CYFRA 21-1 for malignant pleural effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 60s
Year: 2003